Author

A. Musa

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 2 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:rat· 2 Research Focus:drug response / drug discovery· 1 Approach:genetic perturbation / CRISPR· 1 Organism:mouse· 1

Frequent Co-Authors

J. I. Ejiofor· 2 shared M. H. Ahmad· 2 shared M. Watafua· 2 shared A. Satoskar· 1 shared A. Siddiqui· 1 shared C. Meneses· 1 shared F. Oliveira· 1 shared G. Matlashewski· 1 shared

Activity by Year

2020-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPharmacology & Toxicology

J. I. Ejiofor

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Toxicological study on methanol root bark extract of Acacia sieberiana (Fabaceae) in Wistar rats

M. Watafua, J. I. Ejiofor, A. Musa, M. H. Ahmad

This study evaluates the sub-acute toxicity of Acacia sieberiana root bark extract in rats, finding dose-dependent hepatic and renal toxicity but no acute toxicity.

bioRxiv · Jun 24, 2022 · PreprintPharmacology & Toxicology

Acacia sieberiana (Fabaceae) Attenuates Paracetamol and Bile Duct Ligation-Induced Hepatotoxicity via Modulation of Biochemical and Oxidative Stress Biomarkers

M. Watafua, J. I. Ejiofor, A. Musa, M. H. Ahmad

This paper investigates the hepatoprotective effects of Acacia sieberiana root bark extract against paracetamol and bile duct ligation-induced liver damage by modulating biochemical and oxidative stress markers.

bioRxiv · Jun 22, 2022 · PreprintPharmacology & Toxicology

A Second Generation Leishmanization Vaccine with a Markerless Attenuated Leishmania major Strain using CRISPR gene editing

W. W. Zhang, S. Karmakar, S. Gannavaram, R. Dey, P. Lypaczewski, N. Ismail, A. Siddiqui, V. Simonyan, F. Oliveira, I. V. Coutinho-Abreu, T. DeSouza-Vieira, C. Meneses, J. Oristian, T. D. Serfim, A. Musa, , H. L. Nakhasi

This paper describes a CRISPR-edited Leishmania major strain for a second-generation leishmanization vaccine that is marker-free and safe, showing protection in mice comparable to traditional leishmanization.

bioRxiv · May 4, 2020Microbiology